| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.047 | 0.8 |